A detailed history of Prostatis Group LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Prostatis Group LLC holds 1,452,094 shares of TMO stock, worth $890 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
1,452,094
Previous 2,824 51319.76%
Holding current value
$890 Million
Previous $1.63 Billion 9.38%
% of portfolio
0.69%
Previous 0.86%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$508.46 - $591.13 $737 Million - $857 Million
1,449,270 Added 51319.76%
1,452,094 $1.47 Billion
Q1 2023

May 22, 2023

SELL
$535.0 - $604.82 $1,070 - $1,209
-2 Reduced 0.07%
2,824 $1.63 Billion
Q4 2022

Mar 28, 2023

SELL
$484.71 - $571.37 $619,459 - $730,210
-1,278 Reduced 31.14%
2,826 $1.56 Billion
Q4 2022

Mar 23, 2023

SELL
$484.71 - $571.37 $251 Million - $295 Million
-516,995 Reduced 25.22%
1,532,626 $1.56 Billion
Q3 2022

Mar 28, 2023

BUY
$507.19 - $604.49 $605,077 - $721,156
1,193 Added 40.98%
4,104 $2.08 Billion
Q3 2022

Mar 23, 2023

BUY
$507.19 - $604.49 $248 Million - $296 Million
489,824 Added 31.4%
2,049,621 $2.08 Billion
Q2 2022

Mar 28, 2023

SELL
$500.9 - $612.21 $716,787 - $876,072
-1,431 Reduced 32.96%
2,911 $1.58 Billion
Q2 2022

Mar 23, 2023

SELL
$500.9 - $612.21 $429 Million - $525 Million
-857,239 Reduced 35.47%
1,559,797 $1.58 Billion
Q1 2022

Mar 28, 2023

BUY
$524.0 - $644.92 $78,076 - $96,093
149 Added 3.55%
4,342 $2.56 Billion
Q1 2022

Mar 23, 2023

SELL
$524.0 - $644.92 $160 Million - $197 Million
-304,750 Reduced 11.2%
2,417,036 $2.56 Billion
Q4 2021

Mar 28, 2023

BUY
$569.0 - $667.24 $569,000 - $667,240
1,000 Added 31.32%
4,193 $2.8 Billion
Q4 2021

Mar 23, 2023

BUY
$569.0 - $667.24 $520 Million - $610 Million
914,069 Added 50.56%
2,721,786 $2.8 Billion
Q3 2021

Mar 28, 2023

BUY
$509.53 - $609.78 $186,997 - $223,789
367 Added 12.99%
3,193 $1.82 Billion
Q3 2021

Mar 23, 2023

BUY
$509.53 - $609.78 $108 Million - $129 Million
211,545 Added 13.25%
1,807,717 $1.82 Billion
Q2 2021

Mar 28, 2023

BUY
$441.0 - $508.24 $1,764 - $2,032
4 Added 0.13%
3,193 $1.61 Billion
Q2 2021

Mar 23, 2023

BUY
$441.0 - $508.24 $67.1 Million - $77.3 Million
152,161 Added 10.54%
1,596,172 $1.61 Billion
Q1 2021

Mar 28, 2023

BUY
$439.85 - $518.83 $7,477 - $8,820
17 Added 0.54%
3,189 $1.46 Billion
Q1 2021

Mar 23, 2023

SELL
$439.85 - $518.83 $13.1 Million - $15.4 Million
-29,725 Reduced 2.02%
1,444,011 $1.46 Billion
Q4 2020

Mar 28, 2023

SELL
$435.06 - $527.66 $282,353 - $342,451
-649 Reduced 16.99%
3,172 $1.48 Billion
Q4 2020

Mar 23, 2023

SELL
$435.06 - $527.66 $91.3 Million - $111 Million
-209,788 Reduced 12.46%
1,473,736 $1.48 Billion
Q3 2020

Mar 28, 2023

SELL
$359.77 - $441.52 $2,158 - $2,649
-6 Reduced 0.16%
3,821 $1.69 Billion
Q3 2020

Mar 23, 2023

BUY
$359.77 - $441.52 $107 Million - $131 Million
296,849 Added 21.41%
1,683,524 $1.69 Billion
Q2 2020

Mar 28, 2023

SELL
$275.2 - $362.34 $645,894 - $850,411
-2,347 Reduced 38.01%
3,827 $1.39 Billion
Q2 2020

Mar 23, 2023

BUY
$275.2 - $362.34 $83.4 Million - $110 Million
302,947 Added 27.95%
1,386,675 $1.39 Billion
Q1 2020

Mar 28, 2023

SELL
$255.3 - $340.05 $139,904 - $186,347
-548 Reduced 8.15%
6,174 $1.75 Billion
Q1 2020

Mar 23, 2023

SELL
$255.3 - $340.05 $40.3 Million - $53.7 Million
-157,910 Reduced 12.72%
1,083,728 $1.75 Billion
Q4 2019

Mar 28, 2023

SELL
$271.93 - $328.04 $415 Million - $501 Million
-1,525,904 Reduced 99.56%
6,722 $2.18 Billion
Q4 2019

Mar 23, 2023

BUY
$271.93 - $328.04 $338 Million - $407 Million
1,241,638 New
1,241,638 $2.18 Billion

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $240B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Prostatis Group LLC Portfolio

Follow Prostatis Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.